Insider buying last 90 days
$250Kin 1 open-market purchase
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 27 | Alt Aaron E director | Purchase | $250K |
From Form 4 filings, dated to when each was filed.
Close on Sep 18, 2026. Page updated Sep 19, 9:17 pm ET.
Keurig Dr Pepper closes at $30.96, down 1.5%, sitting between its 50-day average of $31.16 and 200-day average of $29.32. The GekkoIndex reads 62.8, placing the stock in the Accumulation zone, up 4.2 over five days. Price stands 23.1% below Gekko Fair Value of $40.26. Over the past six months the stock has returned 14%, and over one year 13.6%, though the one-month return is -0.3%.
This week's coverage centers on leadership and portfolio moves alongside routine corporate items. Executive team changes at Keurig Dr Pepper were noted alongside similar reshuffles at 3M, Dole, and J.M. Smucker. Separately, the company is reported to be looking to extend the approach behind its Dr Pepper brand, which the coverage describes as generating $6 billion in annual sales as the second-largest carbonated soft drink in the U.S., across other parts of its portfolio. A new plastic-free coffee pod system, Alta, was also detailed. On the corporate calendar, KDP declared a quarterly dividend of $0.23 per share, payable 9 October, an annualized $0.92 with a 42.4% payout ratio and a 2.9% yield.
The next earnings date falls on 26 October 2026, before the open, 36 days out and beyond a typical 20-trading-day hold; the prior report on 6 August beat estimates ($0.57 vs $0.54) but drew a -2.4% reaction. In the last 90 days there was 1 insider purchase worth $250,247. Seasonally, the next 20 trading days have averaged -2.3% over 5 years, positive in 2 of those years. Analyst coverage from 14 firms shows 11 buy and 3 hold ratings, with a consensus target of $36.21.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Keurig Dr Pepper scores 4 supportive, 1 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed1 headwind
Averages disagree
Close $30.96 sits between the 50-day ($31.16) and 200-day ($29.32) averages, or the averages disagree.
See the chart62.8, Accumulation
Reading 62.8 is in the Accumulation zone.
See the GekkoIndex23.1% below
Price is 23.1% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: 1 open-market insider purchase.
See smart moneyReports in 36 days
Next report Oct 26, 2026, 36 days away — outside a typical 20-trading-day hold.
See earnings−2.3% on average
From this point in the calendar, the next 20 trading days averaged −2.3% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Keurig Dr Pepper closed at $30.96 on Sep 18, 2026, +13.6% over the past year, inside a 52-week range of $24.88 to $33.82.
Use the left and right arrow keys to read daily values.
Put KDP on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Keurig Dr Pepper makes and sells a broad range of drinks and coffee equipment across the United States and other markets. It is widely recognized for its Keurig brewing systems and K-Cup pods, alongside a lineup of soda, juice and flavored beverage brands sold under many familiar labels.
The business runs through four segments. Coffee Systems covers brewers, pods and coffee blends, sold through retailers, outside distributors and the company's own website. Packaged Beverages makes and ships branded drinks and also produces beverages for private label and emerging brands, plus distribution work for partner labels. Beverage Concentrates supplies liquid concentrates and syrups for names such as Dr Pepper, Canada Dry, 7UP, Snapple, Bai, evian and several others. A separate Latin America unit produces sparkling and purified water, carbonated drinks and vegetable juice under brands including Peñafiel and Clamato. Customers span retailers, bottlers, restaurants, hotels, office coffee services and everyday consumers.
The company was established in 1981 and is headquartered in Burlington, Massachusetts. Its shares are listed on the NASDAQ under the ticker KDP.
Keurig Dr Pepper’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 62.8, in the Accumulation zone, up 4.2 points over five sessions.
Up 4.2 points over five sessions, from the Neutral zone.
Reading for Sep 18, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 44 | −0.6% | −1.3% | ||
| Accumulation (current zone) | 215 | +0.4% | +1.9% | ||
| Neutral | 377 | +0.1% | −0.3% | ||
| Distribution | 25 | −1.9% | −2.2% | ||
| Selling | 1 | Too few readings yet | |||
Average KDP share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Keurig Dr Pepper trades 23.1% below Gekko Fair Value of $40.26, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Keurig Dr Pepper shares are worth, recalculated every trading day.
$40.26
Gekko Fair Value, Sep 19, 2026
23.1% Undervalued
Insiders filed 1 open-market purchase in Keurig Dr Pepper worth $250K, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$250Kin 1 open-market purchase
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 27 | Alt Aaron E director | Purchase | $250K |
From Form 4 filings, dated to when each was filed.
No trades in KDP were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Keurig Dr Pepper has been buying back its own shares.
From company filings.
Keurig Dr Pepper reports on Oct 26, 2026, before the open (36 days away), and beat the EPS estimate in 6 of its last 8 reports.
Oct 26, 2026
Expected before the open, 36 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 6, 2026 | $0.57 est $0.54 | $7.31B est $7.23B | −2.4% |
| Feb 24, 2026 | $0.60 est $0.59 | $4.50B est $4.36B | +1.3% |
| Oct 27, 2025 | $0.54 est $0.54 | $4.31B est $4.15B | +6.2% |
| Jul 24, 2025 | $0.49 est $0.49 | $4.16B est $4.14B | −0.7% |
| Apr 24, 2025 | $0.42 est $0.38 | $3.64B est $3.57B | −2.2% |
| Feb 25, 2025 | $0.58 est $0.57 | $4.07B est $4.01B | −1.1% |
| Oct 24, 2024 | $0.51 est $0.51 | $3.89B est $3.92B | −5.8% |
| Jul 25, 2024 | $0.45 est $0.45 | $3.92B est $3.91B | +3.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Keurig Dr Pepper is $36.21, +17.0% from the last close, from 14 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 14 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 15 | Argus Research | $36 | +16.3% |
| Sep 14 | Bank of America Securities | $38 | +22.7% |
| Sep 14 | Argus Research | $36 | +16.3% |
| Sep 11 | Barclays | $38 | +22.7% |
| Sep 3 | Bernstein | $39 | +26.0% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 19, Keurig Dr Pepper averaged −2.3% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −2.3% | 1 of 5 |
| Next 10 trading days | −4.0% | 0 of 5 |
| Next 15 trading days | −3.4% | 1 of 5 |
| Next 20 trading days | −2.3% | 2 of 5 |
| Next 30 trading days | −2.4% | 3 of 5 |
For scale, KDP’s typical 20-trading-day move in either direction is about 3.6%.
Keurig Dr Pepper’s market cap is $42.12B, with a P/E ratio of 32.1 and revenue of $20.09B over the last twelve months.
Coverage of Keurig Dr Pepper this week reads positive: 8 positive, 7 neutral and 2 negative headlines.
Keurig Dr Pepper’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| KOCoca-Cola | Neutral | 2.8% above |
| MNSTMonster Beverage | Accumulation | 7.1% above |
| CCEPCoca-Cola Europacific Partners | Buying | 8.1% below |
| COKECoca-Cola Consolidated | Neutral | 27.6% below |
| PRMBPrimo Brands | Buying | 40.5% below |
| CELHCelsius | Accumulation | 19.3% below |
A peer links to its own page where one exists.
Keurig Dr Pepper’s market cap is $42.12B at the Sep 18, 2026 close of $30.96, with 1.36B shares outstanding. The shares trade on a P/E ratio of 32.1.
The consensus analyst 12-month price target for Keurig Dr Pepper is $36.21, +17.0% from the last close. Of the 14 firms that rated the stock in the last 90 days, 11 rate it a buy, 3 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Keurig Dr Pepper is undervalued: the Sep 18, 2026 close of $30.96 is 23.1% below Gekko Fair Value of $40.26. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Keurig Dr Pepper is expected to report on Oct 26, 2026, before the market opens (36 days away). Analysts expect earnings of $0.64 per share on revenue of $7.33B. Keurig Dr Pepper beat the earnings estimate in 6 of its last 8 reports, moving 2.8% on average across the report.
Keurig Dr Pepper’s 52-week high is $33.82 and its 52-week low is $24.88; it closed at $30.96 on Sep 18, 2026, +13.6% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 6 items with data read as supportive (gekkoindex, fair value, smart money and earnings risk), 1 as mixed (trend) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.